Hyaluronic Acid Filler Degradation Down With Add-On Botulinum

Share this content:
Hyaluronic Acid Filler Degradation Down With Add-On Botulinum
Hyaluronic Acid Filler Degradation Down With Add-On Botulinum

WEDNESDAY, Jan. 6, 2016 (HealthDay News) -- The combination of hyaluronic acid filler with botulinum neurotoxin type A is associated with reduced degradation, according to an experimental study published in the January issue of Plastic & Reconstructive Surgery.

Ismail Kucuker, M.D., from Ondokuz Mayis University in Samsun, Turkey, and colleagues split the calvaria of a rabbit to mimic the glabellar region in humans in order to assess degradation of hyaluronic acid fillers. Hyaluronic acid alone was applied to one side and hyaluronic acid plus botulinum neurotoxin type A was applied to the other side. Magnetic resonance imaging was performed to assess filler volumes at two days and three months after filler injection.

The researchers found that the average initial volume of filler-only and filler plus botulinum neurotoxin type A was 0.61 cm³ on both sides (P = 0.735). The average degraded volumes of filler-only and filler combined with botulinum neurotoxin were 0.33 and 0.19 cm³, respectively, at the end of three months (P = 0.001). For filler-only and filler combined with botulinum neurotoxin sides, the end volumes were 0.28 and 0.42 cm³, respectively (P < 0.001).

"This study showed that hyaluronic acid filler application in combination with botulinum neurotoxin type A significantly decreases the degradation process and increases the remaining volume of the hyaluronic acid fillers at the end of the paralyzed period," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »